Prestige Wealth Management Group’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-200
Closed -$26.5K 1043
2023
Q4
$26.5K Sell
200
-8
-4% -$875 0.01% 308
2023
Q3
$24.1K Hold
208
0.01% 315
2023
Q2
$32.8K Hold
208
0.01% 303
2023
Q1
$36.4K Sell
208
-19
-8% -$3.19K 0.01% 267
2022
Q4
$30.8K Buy
227
+19
+9% +$2.5K 0.01% 302
2022
Q3
$26K Buy
208
+8
+4% +$1.07K 0.01% 286
2022
Q2
$28K Hold
200
0.01% 287
2022
Q1
$30K Buy
+200
New +$32K 0.01% 287
2021
Q4
Sell
-200
Closed -$28K 1055
2021
Q3
$28K Hold
200
0.01% 323
2021
Q2
$31K Hold
200
0.01% 295
2021
Q1
$28K Hold
200
0.01% 309
2020
Q4
$25K Hold
200
0.01% 323
2020
Q3
$20K Hold
200
0.01% 352
2020
Q2
$20K Hold
200
0.01% 336
2020
Q1
$17K Hold
200
0.01% 312
2019
Q4
$23K Hold
200
0.01% 275
2019
Q3
$22K Hold
200
0.01% 271
2019
Q2
$21K Hold
200
0.01% 267
2019
Q1
$16K Hold
200
0.01% 305
2018
Q4
$16K Buy
+200
New +$16.6K 0.01% 356

Other funds holding SLAB

Prestige Wealth Management Group's SLAB Position: Q1 2024 in Review

Prestige Wealth Management Group sold out of Silicon Laboratories (SLAB) in Q1 2024, closing a stake of 200 shares — an estimated $26.5K sold.

Prestige Wealth Management Group first reported a position in SLAB in Q4 2018 and held it in 20 quarters. The position peaked at $36.4K in Q1 2023. 299 funds tracked by Wall St. Rank hold SLAB as of Q1 2024.

  • Prestige Wealth Management Group reported no remaining Silicon Laboratories position as of Q1 2024 after selling out during the quarter.
  • Prestige Wealth Management Group sold 200 Silicon Laboratories shares in Q1 2024, an estimated $26.5K.
  • Prestige Wealth Management Group first reported a position in Silicon Laboratories in Q4 2018 and held it in 20 quarters.
  • Prestige Wealth Management Group's Silicon Laboratories position peaked at $36.4K in Q1 2023.
  • 299 funds tracked by Wall St. Rank held Silicon Laboratories as of Q1 2024.

Based on Prestige Wealth Management Group's 13F filing for Q1 2024, filed 26 Apr 2024.